Company: CMND
Filing Date: 2025-01-22
Form Type: 20-F
Source: 0001213900-25-005490
Chunk: 260

Company: Clearmind Medicine Inc.
Filing Date: 2025-01-22
Form: 20-F
Item: Item 19
Chunk 260
---
 October 31, 2024, 193,851 common shares with a fair value of $ 269,453 were issued to providers of investor services in payment of services.  

  Share                                                 
  transactions during the year ended October 31, 2023:  
 ────────────────────────────────────────────────────────

  (i)      On November 14, 2022, the Company completed an underwritten public offering of 38,462 common shares at a price to the public of $ 195.00 per share, for aggregate gross proceeds of $ 7.5 million...  

In
addition, the Company granted Aegis Capital Corp. (“ Aegis”), who acted as the underwriters for the deal, a 45 5,769 15 195.00

Aegis
received 1,923 243.75 337,579 The fair value of the underwriters warrants was estimated using the Black-Scholes option pricing
model assuming no expected dividends or forfeitures and the following weighted average assumptions:

  Risk-free interest rate       1.43  
  Expected life (in years)         5  
  Expected volatility            150  

In
connection with the offering, the Company’s common shares were approved for listing on the Nasdaq and began trading on the Nasdaq
(in addition to the CSE) under the symbol “ CMND” on November 15, 2022.

Following
the public offering and pursuant to the Xylo SPA (see note 8e(iii)), Xylo was entitled to receive 1,494 75 1,494 75 296,845

  (ii)      On January 16, 2023, 161 common shares were issued in respect of RSU’s that had been fully vested. The RSU’s had a fair value of $ 39,975 at the time of issuance.  

On
February 22, 2023, 400 110,096

F-25

CLEARMIND
MEDICINE INC.

Notes to
the Consolidated Financial Statements

(Expressed
in United States Dollars)

  Share                

  (iii)      On April 6, 2023, the Company completed an underwritten public offering of 103,249 common shares at a price to the public of $ 23.40 per share and pre-funded warrants to purchase 46,942 common ...  

  (iv)      On May 23,